Mark E. Schneiderhan, PharmD, BCPP

  • 3Articles
  • 16.6KReads1
  • 2014–2023Active
  • 10Collaborators
  • 12Citations2

About

Mark E. Schneiderhan, PharmD, BCPP, is affiliated with the University of Minnesota College of Pharmacy and the Human Development Center, Department of Psychiatry in Duluth, Minnesota. His publications focus on patient care related to antipsychotic treatment, including medication monitoring, cardiometabolic effects, and the role of pharmacists in managing metabolic syndrome in patients prescribed antipsychotics. His work spans quality improvement initiatives and randomized controlled trials conducted between 2014 and 2023.

Publications

PCC
Initiative to Improve Antipsychotic Metabolic Monitoring
PCC
PCC

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.